Gebo Joins ĎAll of Usí Research Program
Dr. Kelly Gebo has joined the All of Us Research Program as chief medical and scientific officer.
She will work with health care professionals and researchers, participants and national and community-based organizations to lead the program’s scientific agenda, with a special focus on populations that have been historically underrepresented in research.
“Kelly has the right combination of research skills, leadership experience and passion for personalized medicine for the job,” said Eric Dishman, director of the program. “I’m delighted to have her join our team in this new position.”
Gebo has clinical, research and educational experience in the health care and higher education sectors. She is a professor of medicine at Johns Hopkins University and an expert in HIV health services research and clinical outcomes of persons with HIV. She has served as co-principal investigator of the HIV Research Network, an 18-year clinical cohort study of high-volume HIV sites caring for more than 20,000 persons with HIV across the country. Her research has been funded through NIH, the Agency for Healthcare Research and Quality and the Health Resources and Services Administration.
Gebo has authored more than 150 peer-reviewed publications, is an elected member of the American Society for Clinical Investigation and has received numerous national awards for her research and teaching.
She is also a leader in higher education, previously serving as an American Council on Education fellow at the University of Pennsylvania and as vice provost for education at Johns Hopkins.
Gebo holds a doctorate in medicine from Johns Hopkins University School of Medicine and a master’s in public health from the Johns Hopkins Bloomberg School of Public Health. She did her internal medicine residency at Johns Hopkins and completed fellowship training in both the Robert Wood Johnson Foundation Clinical Scholars program and in the infectious diseases fellowship training program at Johns Hopkins.
Gebo will maintain her faculty appointment at Johns Hopkins concurrent with her NIH role.
NEIís Redmond Receives Vision Science Award
Dr. T. Michael Redmond, chief of the NEI Laboratory of Retinal Cell and Molecular Biology, was honored with the 2018 António Champalimaud Vision Award on Sept. 4 in Lisbon, Portugal.
This year’s award, shared by Redmond and six other researchers, recognizes scientific contributions that led to the development of the first gene therapy to successfully treat a human disease. Collectively, their achievements led to the development and 2017 approval of voretigene neparvovec-rzyl (Luxturna) for treating Leber congenital amaurosis (LCA), an inherited disorder that causes childhood blindness.
In his 35 years at NEI, Redmond has made foundational scientific discoveries about the molecular biology of the retina, the light-sensing tissue at the back of the eye. Since the early 1990s, he has led research efforts to clone, sequence and characterize the function of the RPE65 gene. His work deduced how the gene converts dietary vitamin A, from sources such as carrots, into a form of the vitamin that is central to the workings of the visual cycle, the enzymatic processes by which the eye converts light into electrical signals that are sent to the brain.
“We owe much to Michael Redmond for setting a course toward an effective gene therapy for LCA,” said NEI director Dr. Paul Sieving.—Kathryn DeMottNINR Welcomes New Advisory Council Members
NINR recently announced the appointment of three new members to its National Advisory Council for Nursing Research.
Dr. Jeffrey A. Kelly is professor of psychiatry and behavioral medicine and director of the Center for AIDS Intervention Research at the Medical College of Wisconsin. His academic career focuses on the application of behavioral science principles to the public health challenge of preventing HIV infection.
Dr. Ida M. (Ki) Moore is the Anne Furrow professor and interim dean at the University of Arizona College of Nursing. For the past 25 years, she has focused on the impact of central nervous system-directed treatment for pediatric acute lymphoblastic leukemia and brain tumors on cognitive outcomes and on mechanisms of tissue injury.
Dr. Nilda (Nena) Peragallo Montano became the seventh dean of the School of Nursing at the University of North Carolina at Chapel Hill in January 2017.
Formerly dean and professor of the University of Miami School of Nursing and Health Studies, she is an internationally recognized nurse scientist specializing in health disparities and culturally competent interventions with minority populations.